Pricing
  1. JP-listed companies
  2. JMS CO.,LTD.
  3. Financials
  4. Net income margin (%)

JMS CO.,LTD.【JP:7702】

Market cap
¥10.7B
P/E ratio
-13.3x
JMS manufactures and sells medical devices and pharmaceuticals globally, serving healthcare markets across Asia, Europe and the Americas.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndNet income margin (%) YoY (%)
Mar 31, 20250.1-331.42%
Mar 31, 2024-0.1-112.51%
Mar 31, 20230.4-68.95%
Mar 31, 20221.4-53.06%
Mar 31, 20213-10.82%
Mar 31, 20203.4+69.51%
Mar 31, 20192+79.27%
Mar 31, 20181.1-47.91%
Mar 31, 20172.1+60.21%
Mar 31, 20161.3+407.60%
Mar 31, 20150.3-31.43%
Mar 31, 20140.4-79.92%
Mar 31, 20131.9+120.76%
Mar 31, 20120.9

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)